Product code NJO— Microbiology
SHERLOCK MYCOBACTERIA IDENTIFICATION SYSTEM
- Classification name
- System, Mycolic Acid Analysis, Mycobacterium Tuberculosis
- Device class
- Class 1
- Regulation
- 21 CFR 866.3370
- Advisory panel
- Microbiology
- Total cleared
- 1
- First cleared
- Most recent
FDA classification definition
“A mycolic acids analysis system is intended to aid in the identification of M. tuberculosis and differentiation from other mycobacteria species through the analysis of mycolic acids derived from cultured bacterial samples, using high performance liquid chromatography (HPLC) performed and pattern recognition software. The system is used, along with other identification methods, to identify mycobacteria that have been isolated from clinical specimens by traditional culturing techniques. Following observation of growth on the solid medium, identification of the mycobacterial isolate is done with extraction and analysis of mycolic acids. Results should be interpreted in conjunction with other laboratory observations and procedures.”
Market context for product code NJO
FDA has cleared device under product code NJO, all in 2002, filed by 1 applicant company. No FDA device recalls reference this product code. Class I devices are low-risk and subject to FDA general controls; many Class I device types are exempt from 510(k) premarket notification.
Top applicants under product code NJO
Recent clearances under product code NJO
Data sourced from openFDA. This site is unofficial and independent of the FDA.